Anti-SPTSSA monoclonal antibody

Pre-made anti-SPTSSA monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SPTSSA/SPTSSA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1816-Ab-1/ GM-Tg-hg-IP1816-Ab-2Anti-Human SPTSSA monoclonal antibodyHuman
GM-Tg-rg-IP1816-Ab-1/ GM-Tg-rg-IP1816-Ab-2Anti-Rat SPTSSA monoclonal antibodyRat
GM-Tg-mg-IP1816-Ab-1/ GM-Tg-mg-IP1816-Ab-2Anti-Mouse SPTSSA monoclonal antibodyMouse
GM-Tg-cynog-IP1816-Ab-1/ GM-Tg-cynog-IP1816-Ab-2Anti-Cynomolgus/ Rhesus macaque SPTSSA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1816-Ab-1/ GM-Tg-felg-IP1816-Ab-2Anti-Feline SPTSSA monoclonal antibodyFeline
GM-Tg-cang-IP1816-Ab-1/ GM-Tg-cang-IP1816-Ab-2Anti-Canine SPTSSA monoclonal antibodyCanine
GM-Tg-bovg-IP1816-Ab-1/ GM-Tg-bovg-IP1816-Ab-2Anti-Bovine SPTSSA monoclonal antibodyBovine
GM-Tg-equg-IP1816-Ab-1/ GM-Tg-equg-IP1816-Ab-2Anti-Equine SPTSSA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1816-Ab-1/ GM-Tg-hg-IP1816-Ab-2; GM-Tg-rg-IP1816-Ab-1/ GM-Tg-rg-IP1816-Ab-2;
GM-Tg-mg-IP1816-Ab-1/ GM-Tg-mg-IP1816-Ab-2; GM-Tg-cynog-IP1816-Ab-1/ GM-Tg-cynog-IP1816-Ab-2;
GM-Tg-felg-IP1816-Ab-1/ GM-Tg-felg-IP1816-Ab-2; GM-Tg-cang-IP1816-Ab-1/ GM-Tg-cang-IP1816-Ab-2;
GM-Tg-bovg-IP1816-Ab-1/ GM-Tg-bovg-IP1816-Ab-2; GM-Tg-equg-IP1816-Ab-1/ GM-Tg-equg-IP1816-Ab-2
Products NameAnti-SPTSSA monoclonal antibody
Formatmab
Target NameSPTSSA
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SPTSSA monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1816-Ag-1Recombinant multi-species SPTSA/ SPTSSA/ C14orf147 protein
    ORF Viral VectorpGMLP003075human SPTSSA Lentivirus plasmid
    ORF Viral VectorvGMLP003075human SPTSSA Lentivirus particle
    ORF Viral VectorpGMLPm002571mouse Sptssa Lentivirus plasmid
    ORF Viral VectorvGMLPm002571mouse Sptssa Lentivirus particle


    Target information

    Target IDGM-IP1816
    Target NameSPTSSA
    Gene ID171546,104725,500651,717580,119872801,111560868,615641
    Gene Symbol and Synonyms1110002B05Rik,C14orf147,C21H14orf147,C7H14orf147,SPTSSA,SSSPTA
    Uniprot AccessionQ969W0,Q4G019,Q5E978
    Uniprot Entry NameSPTSA_HUMAN,SPTSA_RAT,SPTSA_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000165389
    Target ClassificationN/A

    The target: SPTSSA, gene name: SPTSSA, also named as C14orf147, SSSPTA. Serine palmitoyltransferase (SPT; EC 2.3.1.50) catalyzes the first committed and rate-limiting step in sphingolipid biosynthesis. SSSPTA is a small SPT subunit that stimulates SPT activity and confers acyl-CoA preference to the SPT catalytic heterodimer of SPTLC1 (MIM 605712) and either SPTLC2 (MIM 605713) or SPTLC3 (MIM 611120) (Han et al., 2009 [PubMed 19416851]).[supplied by OMIM, Nov 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.